Lexaria Bioscience (LEXX) Stock Chart & Stock Price History $1.04 -0.01 (-0.95%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$1.02 -0.02 (-2.12%) As of 06/11/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Stock Price Performance The Lexaria Bioscience (LEXX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.90%, with a year-to-date return of -50.48%. In the past month, the stock has decreased 3.26%, reflecting recent market activity. As of the latest close, Lexaria Bioscience traded at $1.04 with a market cap of $18.26 million and volume of 1.32 million shares. Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.58%1 Month Performance-3.26%3 Month Performance-27.78%Year-To-Date Performance-50.48%1 Year Performance-67.90% LEXX Stock Chart for Thursday, June, 12, 2025 LEXX Chart by TradingView Lexaria Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$1.05$1.04-0.95%$1.10$0.931.32 million shs$18.26 million06/10/2025$1.00$1.05+5.00%$1.05$0.9652,830 shs$18.44 million06/09/2025$0.99$1.00+1.52%$1.03$0.98130,756 shs$17.56 million06/06/2025$0.99$0.99-0.52%$1.01$0.9747,915 shs$17.30 million06/05/2025$0.96$0.99+3.04%$1.00$0.9537,058 shs$17.39 million06/04/2025$0.92$0.96+4.31%$0.97$0.9347,305 shs$16.87 million06/03/2025$0.98$0.92-5.72%$1.01$0.9256,625 shs$16.18 million06/02/2025$1.01$0.98-3.26%$1.02$0.9659,153 shs$17.16 million05/30/2025$1.04$1.01-2.42%$1.04$0.9840,336 shs$17.74 million05/29/2025$1.02$1.04+1.47%$1.05$1.0245,702 shs$18.17 million Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$1.05$1.02-2.86%$1.04$1.0034,896 shs$17.91 million05/27/2025$1.10$1.05-4.55%$1.09$1.0341,867 shs$18.44 million05/26/2025$1.10$1.10$1.12$0.97313,592 shs$19.32 million05/23/2025$0.97$1.10+13.40%$1.12$0.97313,592 shs$19.32 million05/22/2025$0.96$0.97+1.04%$1.01$0.9556,893 shs$17.03 million05/21/2025$0.98$0.96-2.04%$1.01$0.9561,560 shs$16.86 million05/20/2025$1.00$0.98-2.00%$1.02$0.9741,461 shs$17.21 million05/19/2025$1.01$1.00-0.99%$1.02$0.9598,527 shs$17.56 million05/16/2025$1.03$1.01-1.94%$1.03$1.0082,916 shs$17.74 million05/15/2025$1.06$1.03-2.83%$1.05$1.0258,186 shs$18.09 million05/14/2025$1.07$1.06-0.93%$1.08$1.0551,337 shs$18.61 million05/13/2025$1.08$1.07-0.47%$1.09$1.0570,479 shs$18.79 million05/12/2025$1.08$1.08-0.46%$1.12$1.06128,246 shs$18.88 million Related Companies IMRX Stock Chart IMUX Stock Chart ZIVO Stock Chart XCUR Stock Chart MGX Stock Chart IRD Stock Chart ANL Stock Chart PDSB Stock Chart CTOR Stock Chart ASRT Stock Chart Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
